Cargando…
Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study
BACKGROUND: This study’s objective was to investigate the predictors for severe anemia, severe leukopenia, and severe thrombocytopenia when amphotericin B deoxycholate-based induction therapy is used in HIV-infected patients with talaromycosis. METHODS: A total of 170 HIV-infected patients with tala...
Autores principales: | Zhou, Yihong, Lu, Tao, Li, Yan, Qin, Yuanyuan, Lu, Yanqiu, Tian, Qun, Lan, Ke, Zhou, Guoqiang, Qin, Yingmei, Harypursat, Vijay, Li, Shunmei, Lin, Shide, Chen, Yaokai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588125/ https://www.ncbi.nlm.nih.gov/pubmed/37864131 http://dx.doi.org/10.1186/s12879-023-08394-7 |
Ejemplares similares
-
Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
por: Zhou, Yihong, et al.
Publicado: (2022) -
Multicentre derivation and validation of a prognostic scoring system for mortality assessment in HIV‐infected patients with talaromycosis
por: Qin, Yuanyuan, et al.
Publicado: (2020) -
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
por: Zhao, Ting, et al.
Publicado: (2022) -
Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus–Infected Adults in Vietnam
por: Buchanan, James, et al.
Publicado: (2021) -
Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial
por: Qin, Yuanyuan, et al.
Publicado: (2020)